Cargando…
Methadone switching for refractory cancer pain
BACKGROUND: Methadone is commonly considered an alternative opioid treatment for refractory cancer pain. This study aims to investigate the efficacy, safety, and cost of methadone in the treatment of refractory cancer pain. METHODS: A retrospective study was conducted in patients who used methadone...
Autores principales: | Ding, Haiying, Song, Yu, Xin, Wenxiu, Sun, Jiao, Zhong, Like, Zhou, Qinfei, He, Chaoneng, Gong, Liyan, Fang, Luo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628261/ https://www.ncbi.nlm.nih.gov/pubmed/36324113 http://dx.doi.org/10.1186/s12904-022-01076-2 |
Ejemplares similares
-
Reply to “A better interpretation of data regarding the opioid switching to methadone”
por: Ding, Haiying, et al.
Publicado: (2023) -
Cost-effectiveness of PARP inhibitors in malignancies: A systematic review
por: Ding, Haiying, et al.
Publicado: (2022) -
Spectrum-Effect Relationship-Based Strategy Combined with Molecular Docking to Explore Bioactive Flavonoids from Sceptridium ternatum
por: Zhu, Junfeng, et al.
Publicado: (2022) -
Long Distance From Microvessel to Cancer Cell Predicts Poor Prognosis in Non-Small Cell Lung Cancer Patients
por: Ding, Haiying, et al.
Publicado: (2021) -
A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
por: Zhong, Like, et al.
Publicado: (2023)